Press Releases

PRESS RELEASE For immediate release Devonian Health Group Reports First Quarter 2025 Financial Results and Grants Stock Options First quarter revenues increased by 360% year over year First quarter net loss for the quarter of $ 0.002 per share Grant of 1,535,715 stock...

PRESS RELEASE For immediate release DEVONIAN REPORTS ITS ANNUAL 2024 FINANCIAL RESULTS Fourth quarter revenues of $9 Million increased 749% year over year Annual revenues of $17.8 Million increased 660% year over year Fourth quarter net income of $007 per share Annual...

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE GRANT OF STOCK OPTIONS QUÉBEC, October 8, 2024 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique...

PRESS RELEASE For immediate release DEVONIAN ANNOUNCES AMENDMENT TO ITS ARTICLES OF AMALGAMATION AND RESIGNATION OF ITS INTERIM CHIEF FINANCIAL OFFICER Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, October 7,...

PRESS RELEASE For immediate release DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S CHICAGO VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JULY 17, 2024 Québec, QUÉBEC, July 15, 2024 – Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB:...

PRESS RELEASE For immediate release DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S BOSTON VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JULY 10, 2024 Québec, QUÉBEC, June 25, 2024 – Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB:...

PRESS RELEASE For immediate release Devonian Health Group Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor relations Firm Third quarter revenues increased 1,162% year over year Third quarter net loss for the quarter...

PRESS RELEASE For immediate release Devonian appoints André P. Boulet to Chairman of the Board and Chief Operating Officer Montreal, June 3, 2024 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical...